nocturia
Conditions
Interventions
life style measure
oral administration of ramelteon
Sponsors
Kyoto University Graduate School of Medicine
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: 2 or more of nocturia score in the International Prostate Symptom Score
Exclusion criteria
Exclusion criteria: 1) patiens with definite neurogenic bladder, 2) patients with definite organic disorders in lower urinary tract, 3) patients undergoing insomnia treatment, 4) patients receiving fluvoxamine maleate
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| improvement of global score of the Pittsburgh sleep quality index | — |
Secondary
| Measure | Time frame |
|---|---|
| improvement of other questionnaire, improvement of objective parameters on frequency-volume charts, safety of ramelteon | — |
Countries
Japan
Outcome results
None listed